Publications

Central retinal vein occlusion 36-month outcomes with anti-vascular endothelial growth factors: the Fight Retinal Blindness! registry

Ophthalmol Retina

2022 November

Subretinal fluid may protect against macular atrophy in neovascular age-related macular degeneration: 5 years of follow-up from Fight Retinal Blindness registry

Acta Ophthalmol

2022 December

Clinical Registries in Dry Eye Disease: A Systematic Review

Cornea

2022 December

Five-year corneal cross-linking outcomes: A Save Sight Keratoconus Registry Study

Clinical and Experimental Opthalmology

2022 October

One-year real-world outcomes of bevacizumab for the treatment of macular oedema secondary to retinal vein occlusion

Clinical and Experimental Opthalmology

, epub

2022 October

Oxygen in Corneal Collagen Crosslinking to Treat Keratoconus: A Systematic Review and Meta-Analysis

Asia Pac J Ophthalmol

2022 September

Patient-Reported Outcomes in Keratoconus: A Save Sight Keratoconus Registry Study

Cornea

2022 August

Three-year treatment outcomes of Aflibercept versus Ranibizumab for diabetic macular edema: data from the Fight Retinal Blindness! Registry

Retina

2022 June

12-month outcomes of ranibizumab versus aflibercept for macular oedema in branch retinal vein occlusion: data from the FRB! registry

British Journal of Ophthalmology

2022 June

Efficacy and safety of standard corneal cross-linking procedures performed with short versus standard riboflavin induction: A Save Sight Keratoconus Registry Study

Cornea

2022 May

Incidence, Risk Factors and Outcomes of Rhegmatogenous Retinal Detachment after Intravitreal Injections of Anti-Vascular Endothelial Growth Factor for Retinal Diseases: Data from the Fight Retinal Blindness! Registry

Ophthalmology Retina

, (epub)

2022 May

Changes in 12-month outcomes over time for age-related macular degeneration, diabetic macular oedema and retinal vein occlusion

Eye

, (epub)

2022 May

Initial observation or treatment for diabetic macular oedema with good visual acuity: two-year outcomes comparison in routine clinical practice: data from the Fight Retinal Blindness! Registry

Acta Ophthalmologica

2022 May

Creation of a neovascular age-related macular degeneration national database using a web-based platform: Fight Retinal Blindness Spain. Report 1: Visual outcomes

Clinical and Experimental Ophthalmology

2022 April

Comparative study of 2-year outcomes for Hydrus or iStent inject microinvasive glaucoma surgery implants with cataract surgery

Clinical and Experimental Ophthalmology

2022 April

International impact of the COVID-19 pandemic lockdown on intravitreal therapy outcomes: Fight Retinal Blindness registry

Retina

2022 April

Dexamethasone Implant for Diabetic Macular Oedema: 1-Year Treatment Outcomes from the Fight Retinal Blindness! Registry

Ophthalmology and Therapy

2022 April

Incidence, risk factors and outcomes of submacular haemorrhage with loss of vision in neovascular age-related macular degeneration in daily clinical practice: data from the FRB! registry

Acta Ophthalmology

, (epub)

2022 March

Characterization of poor visual outcomes of diabetic macular edema: the Fight Retinal Blindness! Project

Ophthalmology Retina

, (epub)

2022 March

Bevacizumab for diabetic macular oedema: one-year treatment outcomes from the Fight Retinal Blindness! Registry

Eye

2022 March

Longer treatment intervals are associated with reduced treatment persistence in neovascular age related macular degeneration

Retina

, (epub)

2022 February

Vascular endothelial growth factor inhibitors for predominantly Caucasian myopic choroidal neovascularization: 2-year treatment outcomes in clinical practice: data from the Fight Retinal Blindness! Registry

Acta Ophthalmology

2022 February

Quality of life impact of eye diseases: a Save Sight Registries study

Clinical and Experimental Ophthalmology

, (epub)

2022 January

Hemiretinal vein occlusion 12-month outcomes are unique with vascular endothelial growth factor inhibitors: data from the Fight Retinal Blindness! Registry

British Journal of Ophthalmology

, (epub)

2022 January

The impact of disease activity on 5-year outcomes in patients undergoing treatment for neovascular age-related macular degeneration

Retina

2022 January

The Save Sight Keratoconus Registry – Optometry Module: an opportunity to use real-world data to advance eye care

Clinical and Experimental Ophthalmology

2022 January

Comparative Efficacy and Safety of Standard Versus Accelerated Corneal Crosslinking for Keratoconus: 1-Year Outcomes From the Save Sight Keratoconus Registry Study

Cornea

2021 December

Efficient capture of high-quality real-world data on treatments for glaucoma: the Fight Glaucoma Blindness! Registry

BMJ Open Ophthalmology

2021 November

Three-Year Outcomes of Neovascular Age-Related Macular Degeneration in Eyes That Do Not Develop Macular Atrophy or Subretinal Fibrosis

Transl Vis Sci Technol

2021 November

Extended intervals for wet AMD patients with high retreatment needs: informing the risk during COVID-19, data from real-world evidence

Eye

2021 October

Real-world treatment outcomes of neovascular Age-related Macular Degeneration in the Netherlands

Acta Ophthalmologica

2021 September

Twelve-month treatment outcomes of macular edema following central retinal vein occlusion using aflibercept or ranibizumab in routine clinical practice – data from the Fight Retinal Blindness! project

Acta Ophthalmologica

, (epub)

2021 September

Neovascular age-related macular degeneration at treatment intervals of 14 weeks or greater

Clinical and Experimental Ophthalmology

2021 August

Association between anatomical and clinical outcomes of neovascular age-related macular degeneration treated with anti-VEGF

Retina

2021 July

Treat-and-extend versus fixed bimonthly treatment regimens for treatment-naive neovascular age-related macular degeneration: real world data from the Fight Retinal Blindness registry

Graefe’s Archive for Clinical and Experimental Ophthalmology

2021 June

Predictors of progression in untreated keratoconus: a Save Sight Keratoconus Registry study

British Journal of Ophthalmology

, (epub)

2021 March

Microbial Keratitis After Corneal Collagen Cross-Linking for Corneal Ectasia

Asia-Pacific Journal of Ophthalmology

2021 January

Five-year incidence and visual acuity outcomes for intravitreal therapy in bilateral neovascular age-related macular degeneration: Fight Retinal Blindness! Project

Retina

2021 January

Lifetime Outcomes of Anti-Vascular Endothelial Growth Factor Treatment for Neovascular Age-Related Macular Degeneration

JAMA Ophthalmology

2020 December

Prevalence and risk factors for the development of physician-graded subretinal fibrosis in eyes treated for neovascular age-related macular degeneration

Retina

2020 December

Four-week outcomes of vascular endothelial growth factor inhibitors for neovascular age-related macular degeneration

Clinical and Experimental Ophthalmology

2020 September

Detrimental Effect of Delayed Re-treatment of Active Disease on Outcomes in Neovascular Age-Related Macular Degeneration: The RAMPS Study

Ophthalmology Retina

2020 September

Efficacy and follow-up of anti-VEGF injections in diabetic macular edema in real-life practice at the Dijon university medical centre through the Save Sight Registries

Journal Français d’Ophtalmologie

2020 September

Intraocular Pressure Changes and Vascular Endothelial Growth Factor Inhibitor Use in Various Retinal Diseases: Long-Term Outcomes in Routine Clinical Practice: Data from the Fight Retinal Blindness! Registry

Ophthalmology Retina

2020 September

Smoking status and treatment outcomes of vascular endothelial growth factor inhibitors for neovascular age-related macular degeneration

Retina

2020 September

Changes in real-world treatment patterns for diabetic macular oedema from 2009 to 2019 and 5-year outcomes: Data from the Fight Retinal Blindness! Registry

Clinical and Experimental Ophthalmology

2020 August

Prevalence and characteristics of macular atrophy in eyes with neovascular age-related macular degeneration. A study from a long-term observational dataset: the Fight Retinal Blindness! project

British Journal of Ophthalmology

2020 August

Ten-year outcomes of anti-vascular endothelial growth factor treatment for neovascular age-related macular disease: A single-centre French study

Clinical and Experimental Ophthalmology

2020 July

Twelve-month outcomes of intra-vitreal anti-VEGF agents for treatment-naïve neovascular age-related macular degeneration eyes: French data from the fight for retinal blindness!

Journal Français d’Ophtalmologie

2020 July

Ranibizumab or Aflibercept for Diabetic Macular Edema: Comparison of 1-Year Outcomes from the Fight Retinal Blindness! Registry

Ophthalmology

2020 May

Outcomes of cataract surgery in eyes with diabetic macular oedema: Data from the Fight Retinal Blindness! Registry

Clinical and Experimental Ophthalmology

2020 May

Assessing the accuracy of a large observational registry of neovascular age-related macular degeneration

Retina

2020 May

The Impact on Work Patterns of Implementing the Save Sight Keratoconus Registry in the Hospital Setting

Cornea

2020 April

Psychometric Properties of the Keratoconus Outcomes Research Questionnaire: A Save Sight Keratoconus Registry Study

Cornea

2020 March

Measurement of Quality of Life in Keratoconus

Cornea

2020 March

Treatment Outcomes of Ranibizumab versus Aflibercept for Neovascular Age-Related Macular Degeneration: Data from the Fight Retinal Blindness! Registry

Ophthalmology

2020 March

Ten-Year Treatment Outcomes of Neovascular Age-Related Macular Degeneration from Two Regions

American Journal of Ophthalmology

2020 February

Type 3 neovascularisation (retinal angiomatous proliferation) treated with antivascular endothelial growth factor: real-world outcomes at 24 months

British Journal of Ophthalmology

2019 September

Outcomes of Suspending VEGF Inhibitors for Neovascular Age-Related Macular Degeneration When Lesions Have Been Inactive for 3 Months

Ophthalmology Retina

2019 August

Five-Year Real-World Outcomes of Occult and Classic Choroidal Neovascularization: Data From the Fight Retinal Blindness! Project

American Journal of Ophthalmology

2019 August

Trainee-led versus specialist-led management of neovascular age-related macular degeneration: a registry-based study

British Journal of Ophthalmology

2019 August

Keratoconus Natural Progression: A Systematic Review and Meta-analysis of 11529 Eyes

Ophthalmology

2019 July

Clinical Registries in Ophthalmology

Ophthalmology

2019 May

Vision-Related Quality of Life in Keratoconus: A Save Sight Keratoconus Registry Study

Cornea

2019 May

Characterization of Poor Visual Outcomes of Neovascular Age-related Macular Degeneration Treated with Anti-Vascular Endothelial Growth Factor Agents

Ophthalmology

2019 May

A Multicountry Comparison of Real-World Management and Outcomes of Polypoidal Choroidal Vasculopathy: Fight Retinal Blindness! Cohort

Ophthalmology Retina

2019 March

Projection of Long-Term Visual Acuity Outcomes Based on Initial Treatment Response in Neovascular Age-Related Macular Degeneration

Ophthalmology

2019 January

Ranibizumab and Aflibercept for the treatment of pigment epithelial detachment in neovascular age-related macular degeneration: Data from an Observational Study

Retina

2018 October

A pharmacoepidemiologic study of ranibizumab and aflibercept use 2013-2016. The Fight Retinal Blindness! Project

Graefe’s Archive for Clinical and Experimental Ophthalmology

2018 October

Outcomes and Predictive Factors After Cataract Surgery in Patients With Neovascular Age-related Macular Degeneration. The Fight Retinal Blindness! Project

American Journal of Ophthalmology

2018 June

Outcomes in Neovascular Age-Related Macular Degeneration when Neovascular Lesion Activity Is Uncertain: Observational Study

Ophthalmology Retina

2018 June

Real-world visual outcomes in patients with neovascular age-related macular degeneration receiving aflibercept at fixed intervals as per UK licence

Clinical and Experimental Ophthalmology

2018 May

Clinical and social characteristics associated with reduced visual acuity at presentation in Australian patients with neovascular age-related macular degeneration: a prospective study from a long-term data set.

Clinical and Experimental Ophthalmology

2018 April

Early and Late Retinal Pigment Epithelium Tears after Anti-Vascular Endothelial Growth Factor Therapy for Neovascular Age-Related Macular Degeneration

Ophthalmology

2018 February

Incidence and Outcomes of Infectious and Noninfectious Endophthalmitis after Intravitreal Injections for Age-Related Macular Degeneration

Ophthalmology

2018 January

Two year outcomes of “treat and extend” intravitreal therapy using aflibercept preferentially for neovascular age-related macular degeneration

Retina

2018 January

Re: Comparison of Age-Related Macular Degeneration Treatments Trials (CATT) Research Group: Five-year outcomes with anti-vascular endothelial growth factor treatment of neovascular age-related macular degeneration: The Comparison of Age-Related Macular Degeneration Treatments Trials

Ophthalmology

2017 March

Seven-year Trends in Visual Acuity at First Presentation in Patients with Neovascular AMD

Ophthalmology

2017 February

Twelve-Month Outcomes of Ranibizumab vs. Aflibercept for Neovascular Age-Related Macular Degeneration: Data from an Observational Study

Ophthalmology

2016 December

Effects of switching from ranibizumab to aflibercept in eyes with exudative age-related macular degeneration

British Journal of Ophthalmology

2016 December

Treatment Patterns and Visual Outcomes during the Maintenance Phase of Treat-and-Extend Therapy for Age-Related Macular Degeneration

Ophthalmology

2016 November

Long-Term Outcomes of Treatment of Neovascular Age-Related Macular Degeneration: Data from an Observational Study

Ophthalmology

2015 September

Two-year outcomes of “treat and extend” intravitreal therapy for neovascular age-related macular degeneration

Ophthalmology

2015 June

Time to initial clinician-reported inactivation of neovascular age-related macular degeneration treated primarily with ranibizumab

Ophthalmology

2015 March

Outcomes of persistently active neovascular age-related macular degeneration treated with VEGF inhibitors: observational study data

British Journal of Ophthalmology

2015 March

Consequences of long-term discontinuation of vascular endothelial growth factor inhibitor therapy in the patients with neovascular age-related macular degeneration

Acta Ophthalmologica

2014 December

Intravitreal therapy in bilateral neovascular age-related macular degeneration

Ophthalmology

2014 October

Reasons for discontinuation of intravitreal vascular endothelial growth factor inhibitors in neovascular age-related macular degeneration

Retina

2014 September

Comparison of outcomes from a phase 3 study of age-related macular degeneration with a matched, observational cohort

Ophthalmology

2014 March

Efficient capture of high-quality data on outcomes of treatment for macular diseases: the fight retinal blindness! Project

Retina

2014 January

Prospective Audit of Exudative Age-Related Macular Degeneration: 12-Month Outcomes in Treatment-Naïve Eyes

Investigative Ophthalmology and Visual Science

2013 August

Publications

Follow us

Quick links